asa guidelines for glp-1 agonists and Anesthesia: Considerations and Cautions CRNAs GLP1 agonists: current and future
Description
Although no studies have investigated the expression of GLP-1/GLP-1R in Hoffa's tissue, several studies focused on the role of GLP-1 in white or brown adipose tissue [75,76]
Collectively, emerging evidence suggests that the most effective approach to prevent muscle wasting during GLP-1RA therapy combines nutritional and exercise strategies, with a multidisciplinary clinical management involving physicians, dietitians and exercise specialists to tailor interventions based on individual goals, comorbidities and age
June 24, 2024
LY3437943 is a C20-diacid acylated compound that favors GIPR activity albeit with balanced activity between GLP-1R and GcgR in vitro
Where Things Stand Right Now Lilly has submitted orforglipron for regulatory review in over 40 countries
